Skip to main content

Advertisement

Table 4 Factors associated with appropriateness of ceftriaxone utilization in the medicine wards of general hospitals in AA; February 2014 (n = 477)

From: Evaluation of Ceftriaxone utilization in internal medicine wards of general hospitals in Addis Ababa, Ethiopia: a comparative retrospective study

     Crude Adjusted
Factors N % OR 95 % CI OR 95 % CI
Public hospital Age
 14–65 Yrs. 329 87.5 1.34 0.72–2.49 0.80 0.40–1.50
 >65 Yrs. 47 12.5 1.00 1.00 1.00 1.00
Sex
 Male 172 45.7 0.91 0.61–1.37 0.95 0.60–1.5
 Female 204 54.3 1.00 1.00 1.00 1.00
Days of hospital stays
 0–7 days 110 29.25 1.00 1.00 1.00 1.00
 8–14 days 133 35.40 5.90 3.30–10.50 6.00 3.40–10.80
 >14 days 133 35.40 5.710 3.20–10.15 5.58 3.10–10.00
Co morbidity
 0 60 16.0 1.00 1.00 1.00 1.00
 > = 1 316 84.0 1.68 0.95-2.95 1.60 0.89–3.00
Co-prescribed
 0 6 1.6 1.00 1.00 1.00 1.00
 > = 1 370 98.4 0.95 0.19–4.807 1.10 0.20–6.00
Private hospital Age
 14–65 Yrs. 73 72.3 0.64 0.34–1.94 1.60 0.60–4.00
 >65 Yrs. 28 27.7 1.00 1.00 1.00 1.00
Sex       
 Male 68 67.3 1.40 0.59–3.34 1.20 0.50–3.10
 Female 33 32.7 1.00 1.00 1.00 1.00
Days of hospital stay
 0–7 days 76 75.2 1.00 1.00 1.00 1.00
 8–14 days 17 16.8 3.00 1.00–9.11 3.00 1.00–9.12
 >14 days 8 8.0 3.61 0.80–16.37 3.50 0.75–16.58
Comorbidity
 0 37 36.6 1.00 1.00 1.00 1.00
 > = 1 64 63.4 1.50 0.65–3.55 1.23 0.48–3.20
Co-prescribed
 0 2 2.0 1.00. 1.00 1.00 1.00
 >1 99 98.0 0.63 0.03–10.30 0.38 0.02–6.73